These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38943212)

  • 1. Discovery of Loureirin analogues with colorectal cancer suppressive activity via regulating cell cycle and Fas death receptor.
    Li P; Tian X; Zhang D; Ou H; Huang Q; Jin W; Liu R
    BMC Pharmacol Toxicol; 2024 Jun; 25(1):36. PubMed ID: 38943212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
    Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
    Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
    Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loureirin A Promotes Cell Differentiation and Suppresses Migration and Invasion of Melanoma Cells via WNT and AKT/mTOR Signaling Pathways.
    Xia ZY; Liu L; Kuok CF; Wang XL; Shi D; Ma Q; Cheng XY; Wang GL; Li MJ; Zheng QS; Liu XN; Li DF; Li BH
    Biol Pharm Bull; 2024 Feb; 47(2):486-498. PubMed ID: 38199251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance.
    Riaz S; Iqbal M; Ullah R; Zahra R; Chotana GA; Faisal A; Saleem RSZ
    Bioorg Chem; 2019 Jun; 87():123-135. PubMed ID: 30884306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
    Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
    Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
    Park YL; Ha SY; Park SY; Choi JH; Jung MW; Myung DS; Kim HS; Joo YE
    Int J Oncol; 2019 May; 54(5):1875-1883. PubMed ID: 30864676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
    Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
    Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation.
    Lee HY; Tang DW; Liu CY; Cho EC
    Chem Biol Interact; 2022 Jan; 352():109778. PubMed ID: 34929181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
    Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF; Hassaneen HM; Abdelhamid IA
    Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
    Kim YJ; Kang KS; Choi KC; Ko H
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2559-64. PubMed ID: 25959811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.
    Mohamed MF; Sroor FM; Ibrahim NS; Salem GS; El-Sayed HH; Mahmoud MM; Wagdy MM; Ahmed AM; Mahmoud AT; Ibrahim SS; Ismail MM; Eldin SM; Saleh FM; Hassaneen HM; Abdelhamid IA
    Invest New Drugs; 2021 Feb; 39(1):98-110. PubMed ID: 32856275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.
    Wang Y; Hedblom A; Koerner SK; Li M; Jernigan FE; Wegiel B; Sun L
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5703-5706. PubMed ID: 27810244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.
    Wang G; Qiu J; Xiao X; Cao A; Zhou F
    Bioorg Chem; 2018 Feb; 76():249-257. PubMed ID: 29197743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
    Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
    Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
    Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
    Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
    Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
    Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.